Variable | Overall survival (%) | Cancer-specific survival (%) | ||||||
---|---|---|---|---|---|---|---|---|
RCC | LCC | ReC | P | RCC | LCC | ReC | P | |
All | 70.1 | 74.2 | 77.1 | <0.0001 | 80.9 | 83.7 | 86.7 | 0.455 |
Stage | ||||||||
Localized | 76.4 | 79.3 | 82.5 | 0.022 | 89.3 | 88.8 | 91.0 | 0.115 |
Regional | 67.9 | 72.4 | 70.1 | 0.010 | 77.7 | 81.8 | 81.1 | 0.143 |
Distant | 36.6 | 45.5 | 32.1 | 0.775 | 46.1 | 52.2 | 51.0 | 0.929 |
Unknown | 77.2 | 67.1 | 77.8 | 0.046 | 80.5 | 83.2 | 86.7 | 0.436 |
Grade | ||||||||
I | 72.3 | 80.8 | 78.9 | 0.693 | 86.3 | 90.5 | 87.8 | 0.901 |
II | 67.5 | 71.2 | 75.3 | 0.002 | 79.0 | 81.5 | 85.7 | 0.09 |
III | 67.2 | 73.7 | 74.1 | 0.143 | 78.7 | 82.0 | 81.2 | 0.294 |
Unknown | 79.8 | 78.9 | 83.1 | 0.361 | 84.3 | 86.2 | 86.2 | 0.545 |
Race | ||||||||
White | 70.4 | 74.6 | 77.6 | <0.0001 | 81.1 | 75.5 | 86.0 | 0.191 |
Black | 61.7 | 69.2 | 69.4 | 0.687 | 84.1 | 76.9 | 84.4 | 0.150 |
Others | 75.7 | 73.9 | 78.1 | 0.700 | 87.2 | 79.2 | 87.0 | 0.575 |
Gender | ||||||||
Male | 67.1 | 72.2 | 73.8 | 0.011 | 79.4 | 83.0 | 73.8 | 0.452 |
Female | 72.8 | 76.8 | 81.8 | 0.001 | 82.3 | 84.6 | 88.9 | 0.454 |
Year of diagnosis | ||||||||
1973–1985 | 77.1 | 80.2 | 84.3 | 0.002 | 85.1 | 87.5 | 90.6 | 0.372 |
1986–1995 | 71.2 | 74.0 | 76.5 | 0.768 | 83.0 | 83.6 | 85.1 | 0.514 |
1996–2005 | 47.1 | 53.9 | 54.8 | 0.327 | 63.1 | 69.4 | 75.7 | 0.870 |
Age at diagnosis | ||||||||
≤ 50 | 83.5 | 81.3 | 90.1 | 0.779 | 87.5 | 83.1 | 91.5 | 0.053 |
51–60 | 76.1 | 80.8 | 87.7 | 0.295 | 82.8 | 86.0 | 92.5 | 0.344 |
61–70 | 77.6 | 80.1 | 80.9 | 0.427 | 85.5 | 87.4 | 89.6 | 0.965 |
71–80 | 67.6 | 68.5 | 71.5 | 0.458 | 80.4 | 81.3 | 83.6 | 0.452 |
≥ 81 | 48.2 | 52.2 | 46.8 | 0.225 | 67.4 | 72.0 | 65.8 | 0.470 |